Similar articles

• Vasoactive intestinal peptide as a mediator of intercellular communication in the cerebral cortex. Release, receptors, actions, and interactions with norepinephrine.

  Magistretti PJ, Dietl MM, Hof PR, Martin JL, Palacios JM, Schaad N, Schorderet M. Magistretti PJ, et al. Ann N Y Acad Sci. 1988;527:110-29. doi: 10.1111/j.1749-6632.1988.tb26977.x. Ann N Y Acad Sci. 1988. PMID: 2839076 Review. No abstract available.
• Identification of high affinity receptors for vasoactive intestinal peptide on human lymphocytes of B cell lineage.

  O'Dorisio MS, Shannon BT, Fleshman DJ, Campolito LB. O'Dorisio MS, et al. J Immunol. 1989 May 15;142(10):3533-6. J Immunol. 1989. PMID: 2541199
• VIP and the skin.

  [No authors listed] [No authors listed] Lancet. 1991 Apr 13;337(8746):886-8. Lancet. 1991. PMID: 1672973 No abstract available.
• Binding sites for pituitary adenylate cyclase activating polypeptide (PACAP): comparison with vasoactive intestinal polypeptide (VIP) binding site localization in rat brain sections.

  Masuo Y, Ohtaki T, Masuda Y, Tsuda M, Fujino M. Masuo Y, et al. Brain Res. 1992 Mar 13;575(1):113-23. doi: 10.1016/0006-8993(92)90430-h. Brain Res. 1992. PMID: 1324082
• Expression and regulatory role of receptors for vasoactive intestinal peptide in bone cells.

  Lundberg P, Lerner UH. Lundberg P, et al. Microsc Res Tech. 2002 Jul 15;58(2):98-103. doi: 10.1002/jemt.10124. Microsc Res Tech. 2002. PMID: 12203709 Review.